• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2,3,5-三取代和 1,2,3,5-四取代吲哚作为 GluK1/GluK2 受体非竞争性拮抗剂的实验和计算结构研究。

Experimental and Computational Structural Studies of 2,3,5-Trisubstituted and 1,2,3,5-Tetrasubstituted Indoles as Non-Competitive Antagonists of GluK1/GluK2 Receptors.

机构信息

Department of General and Coordination Chemistry and Crystallography, Institute of Chemical Sciences, Faculty of Chemistry, Maria Curie-Skłodowska University in Lublin, M. Curie-Skłodowskiej Sq. 2, PL-20031 Lublin, Poland.

Pharmaceutical Substances with Computer Modeling Laboratory, Department of Synthesis and Chemical Technology, Faculty of Pharmacy, Medical University of Lublin, 4A Chodźki St., PL-20093 Lublin, Poland.

出版信息

Molecules. 2022 Apr 12;27(8):2479. doi: 10.3390/molecules27082479.

DOI:10.3390/molecules27082479
PMID:35458681
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9032324/
Abstract

The blockade of kainate receptors, in particular with non-competitive antagonists, has-due to their anticonvulsant and neuroprotective properties-therapeutic potential in many central nervous system (CNS) diseases. Deciphering the structural properties of kainate receptor ligands is crucial to designing medicinal compounds that better fit the receptor binding pockets. In light of that fact, here, we report experimental and computational structural studies of four indole derivatives that are non-competitive antagonists of GluK1/GluK2 receptors. We used X-ray studies and Hirshfeld surface analysis to determine the structure of the compounds in the solid state and quantum chemical calculations to compute HOMO and LUMO orbitals and the electrostatic potential. Moreover, non-covalent interaction maps were also calculated. It is worth emphasizing that compounds and are achiral molecules crystallising in non-centrosymmetric space groups, which is a relatively rare phenomenon.

摘要

亲环素抑制剂,特别是非竞争性拮抗剂,由于其具有抗惊厥和神经保护作用,因此在许多中枢神经系统(CNS)疾病中具有治疗潜力。阐明亲环素受体配体的结构特性对于设计更适合受体结合口袋的药物化合物至关重要。有鉴于此,在这里,我们报告了对四种吲哚衍生物的实验和计算结构研究,这些化合物是非 GluK1/GluK2 受体的竞争性拮抗剂。我们使用 X 射线研究和 Hirshfeld 表面分析来确定化合物在固态中的结构,并进行量子化学计算以计算 HOMO 和 LUMO 轨道和静电势。此外,还计算了非共价相互作用图。值得强调的是,化合物 和 是手性分子,在非中心对称空间群中结晶,这是一种相对罕见的现象。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f98f/9032324/ac60fe5626e3/molecules-27-02479-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f98f/9032324/7a161311e921/molecules-27-02479-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f98f/9032324/43fa954fd677/molecules-27-02479-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f98f/9032324/a1cc1af996b6/molecules-27-02479-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f98f/9032324/6d2ea1651f70/molecules-27-02479-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f98f/9032324/842c986c45d5/molecules-27-02479-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f98f/9032324/0a095805a931/molecules-27-02479-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f98f/9032324/f42422021be5/molecules-27-02479-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f98f/9032324/9348a023e1cf/molecules-27-02479-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f98f/9032324/724aec114d89/molecules-27-02479-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f98f/9032324/c7e90aa36bf7/molecules-27-02479-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f98f/9032324/aeca632affe7/molecules-27-02479-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f98f/9032324/29d0d12acf03/molecules-27-02479-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f98f/9032324/ac60fe5626e3/molecules-27-02479-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f98f/9032324/7a161311e921/molecules-27-02479-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f98f/9032324/43fa954fd677/molecules-27-02479-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f98f/9032324/a1cc1af996b6/molecules-27-02479-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f98f/9032324/6d2ea1651f70/molecules-27-02479-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f98f/9032324/842c986c45d5/molecules-27-02479-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f98f/9032324/0a095805a931/molecules-27-02479-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f98f/9032324/f42422021be5/molecules-27-02479-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f98f/9032324/9348a023e1cf/molecules-27-02479-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f98f/9032324/724aec114d89/molecules-27-02479-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f98f/9032324/c7e90aa36bf7/molecules-27-02479-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f98f/9032324/aeca632affe7/molecules-27-02479-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f98f/9032324/29d0d12acf03/molecules-27-02479-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f98f/9032324/ac60fe5626e3/molecules-27-02479-g012.jpg

相似文献

1
Experimental and Computational Structural Studies of 2,3,5-Trisubstituted and 1,2,3,5-Tetrasubstituted Indoles as Non-Competitive Antagonists of GluK1/GluK2 Receptors.2,3,5-三取代和 1,2,3,5-四取代吲哚作为 GluK1/GluK2 受体非竞争性拮抗剂的实验和计算结构研究。
Molecules. 2022 Apr 12;27(8):2479. doi: 10.3390/molecules27082479.
2
Structural studies, homology modeling and molecular docking of novel non-competitive antagonists of GluK1/GluK2 receptors.GluK1/GluK2受体新型非竞争性拮抗剂的结构研究、同源建模与分子对接
Bioorg Med Chem. 2014 Jan 15;22(2):787-95. doi: 10.1016/j.bmc.2013.12.013. Epub 2013 Dec 12.
3
Binding and selectivity of the marine toxin neodysiherbaine A and its synthetic analogues to GluK1 and GluK2 kainate receptors.海洋毒素 neodysiherbaine A 及其合成类似物与 GluK1 和 GluK2 型 kainate 受体的结合和选择性。
J Mol Biol. 2011 Oct 28;413(3):667-83. doi: 10.1016/j.jmb.2011.08.043. Epub 2011 Aug 26.
4
Agonist binding to the GluK5 subunit is sufficient for functional surface expression of heteromeric GluK2/GluK5 kainate receptors.激动剂与 GluK5 亚基的结合足以使异源 GluK2/GluK5 型 kainate 受体实现功能性的表面表达。
Cell Mol Neurobiol. 2013 Nov;33(8):1099-108. doi: 10.1007/s10571-013-9976-x. Epub 2013 Aug 23.
5
Structural and pharmacological characterization of phenylalanine-based AMPA receptor antagonists at kainate receptors.苯丙氨酸基 AMPA 受体拮抗剂在海人藻酸受体上的结构和药理学特征。
ChemMedChem. 2012 Oct;7(10):1793-8. doi: 10.1002/cmdc.201100599. Epub 2012 Mar 7.
6
Crystal structure of the GluK1 ligand-binding domain with kainate and the full-spanning positive allosteric modulator BPAM538.GluK1 配体结合域与 kainate 的晶体结构及全跨度正变构调节剂 BPAM538。
J Struct Biol. 2024 Sep;216(3):108113. doi: 10.1016/j.jsb.2024.108113. Epub 2024 Jul 28.
7
Mapping the ligand binding sites of kainate receptors: molecular determinants of subunit-selective binding of the antagonist [3H]UBP310.绘制 kainate 受体的配体结合位点图谱:拮抗剂 [3H]UBP310 对亚基选择性结合的分子决定因素。
Mol Pharmacol. 2010 Dec;78(6):1036-45. doi: 10.1124/mol.110.067934. Epub 2010 Sep 13.
8
N1-Substituted Quinoxaline-2,3-diones as Kainate Receptor Antagonists: X-ray Crystallography, Structure-Affinity Relationships, and in Vitro Pharmacology.N1-取代喹喔啉-2,3-二酮作为红藻氨酸受体拮抗剂:X 射线晶体学、构效关系和体外药理学。
ACS Chem Neurosci. 2019 Mar 20;10(3):1841-1853. doi: 10.1021/acschemneuro.8b00726. Epub 2019 Jan 23.
9
Lessons from crystal structures of kainate receptors.海人藻酸受体晶体结构的启示。
Neuropharmacology. 2017 Jan;112(Pt A):16-28. doi: 10.1016/j.neuropharm.2016.05.014. Epub 2016 May 26.
10
Pharmacological activity of C10-substituted analogs of the high-affinity kainate receptor agonist dysiherbaine.C10 取代高亲和力海人藻酸受体激动剂二氢石蒜碱类似物的药理学活性。
Neuropharmacology. 2010 Mar;58(3):640-9. doi: 10.1016/j.neuropharm.2009.11.013. Epub 2009 Dec 4.

引用本文的文献

1
Cl, Na and Mg Adsorption and Electronic Properties on 2-Octyl Acrylate and Isobornyl Acrylate Monomers: A Comprehensive DFT Study.氯离子、钠离子和镁离子在丙烯酸2-辛酯和丙烯酸异冰片酯单体上的吸附及电子性质:一项全面的密度泛函理论研究
Polymers (Basel). 2025 Mar 18;17(6):799. doi: 10.3390/polym17060799.
2
Antimalarial Dibenzannulated Medium-Ring Keto Lactams.抗疟二苯并稠合中环酮内酰胺
ACS Infect Dis. 2023 Oct 13;9(10):1964-1980. doi: 10.1021/acsinfecdis.3c00245. Epub 2023 Sep 11.
3
Kainate Receptor Antagonists: Recent Advances and Therapeutic Perspective.

本文引用的文献

1
Subunit-selective iGluR antagonists can potentiate heteromeric receptor responses by blocking desensitization.亚单位选择性 iGluR 拮抗剂通过阻断脱敏作用增强异源受体反应。
Proc Natl Acad Sci U S A. 2020 Oct 13;117(41):25851-25858. doi: 10.1073/pnas.2007471117. Epub 2020 Sep 30.
2
: from visualization to analysis, design and prediction.从可视化到分析、设计与预测。
J Appl Crystallogr. 2020 Feb 1;53(Pt 1):226-235. doi: 10.1107/S1600576719014092.
3
Practical High-Quality Electrostatic Potential Surfaces for Drug Discovery Using a Graph-Convolutional Deep Neural Network.
激动型氨基酸受体拮抗剂:最新进展及治疗展望。
Int J Mol Sci. 2023 Jan 18;24(3):1908. doi: 10.3390/ijms24031908.
4
Synthesis, Structural and Behavioral Studies of Indole Derivatives D2AAK5, D2AAK6 and D2AAK7 as Serotonin 5-HT and 5-HT Receptor Ligands.吲哚衍生物 D2AAK5、D2AAK6 和 D2AAK7 的合成、结构和行为研究作为血清素 5-HT 和 5-HT 受体配体。
Molecules. 2023 Jan 2;28(1):383. doi: 10.3390/molecules28010383.
基于图卷积深度神经网络的药物发现实用高质量静电势表面。
J Med Chem. 2020 Aug 27;63(16):8778-8790. doi: 10.1021/acs.jmedchem.9b01129. Epub 2019 Sep 25.
4
A Reusable MOF-Supported Single-Site Zinc(II) Catalyst for Efficient Intramolecular Hydroamination of o-Alkynylanilines.一种用于高效邻炔基苯胺分子内氢胺化反应的可重复使用的金属有机框架负载单中心锌(II)催化剂。
Angew Chem Int Ed Engl. 2019 Jun 3;58(23):7687-7691. doi: 10.1002/anie.201902171. Epub 2019 May 2.
5
Synthesis, Structural and Thermal Studies of 3-(1-Benzyl-1,2,3,6-tetrahydropyridin-4-yl)-5-ethoxy-1-indole (D2AAK1_3) as Dopamine D₂ Receptor Ligand.3-(1-苄基-1,2,3,6-四氢吡啶-4-基)-5-乙氧基-1-吲哚(D2AAK1_3)作为多巴胺 D₂ 受体配体的合成、结构和热研究。
Molecules. 2018 Sep 4;23(9):2249. doi: 10.3390/molecules23092249.
6
Reversible crystal-to-crystal chiral resolution: making/breaking non-bonding SO interactions.可逆的晶型到晶型手性拆分:形成/破坏非键合的硫氧相互作用
Chem Commun (Camb). 2017 Apr 4;53(28):3964-3966. doi: 10.1039/c7cc00907k.
7
Crystal structures of four indole derivatives as possible cannabinoid allosteric antagonists.四种吲哚衍生物作为潜在大麻素变构拮抗剂的晶体结构
Acta Crystallogr E Crystallogr Commun. 2015 May 20;71(Pt 6):654-9. doi: 10.1107/S2056989015008476. eCollection 2015 Jun 1.
8
Synthesis and molecular docking of novel non-competitive antagonists of GluK2 receptor.GluK2受体新型非竞争性拮抗剂的合成与分子对接
Med Chem Res. 2015;24(2):810-817. doi: 10.1007/s00044-014-1171-1. Epub 2014 Jul 24.
9
Crystal structure refinement with SHELXL.使用SHELXL进行晶体结构精修。
Acta Crystallogr C Struct Chem. 2015 Jan;71(Pt 1):3-8. doi: 10.1107/S2053229614024218. Epub 2015 Jan 1.
10
Structural studies, homology modeling and molecular docking of novel non-competitive antagonists of GluK1/GluK2 receptors.GluK1/GluK2受体新型非竞争性拮抗剂的结构研究、同源建模与分子对接
Bioorg Med Chem. 2014 Jan 15;22(2):787-95. doi: 10.1016/j.bmc.2013.12.013. Epub 2013 Dec 12.